Unknown

Dataset Information

0

Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol.


ABSTRACT: Glioblastoma multiform (GBM) is by far the most malignant glioma. We have introduced a new treatment for GBMs that comprises the inhalation of a naturally occurring terpene with chemotherapeutic properties known as perillyl alcohol (POH). Clinical trial results on recurrent GBM patients showed that POH extends the average life by more than eight months, temporarily slows tumor growth, and in some cases even decreases tumor size. After approximately seven months, the tumor continues to grow and leads to a dismal prognosis. To investigate how these tumors become resistant to POH, we generated an A172 human glioblastoma cell culture tolerant to 0.06 mM of POH (A172r). We used Multidimensional Protein Identification Technology (MudPIT) to compare the protein expression profile of A172r cells to the established glioblastoma A172 cell line. Our results include a list of identified proteins unique to either the resistant or the nonresistant cell line. These proteins are related to cellular growth, negative apoptosis regulation, Ras pathway, and other key cellular functions that could be connected to the underlying mechanisms of resistance.

SUBMITTER: de Saldanha da Gama Fischer J 

PROVIDER: S-EPMC3017632 | biostudies-literature | 2011 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol.

de Saldanha da Gama Fischer Juliana J   Costa Carvalho Paulo P   da Fonseca Clovis Orlando CO   Liao Lujian L   Degrave Wim M WM   da Gloria da Costa Carvalho Maria M   Yates John R JR   Domont Gilberto B GB  

Journal of proteome research 20100927 1


Glioblastoma multiform (GBM) is by far the most malignant glioma. We have introduced a new treatment for GBMs that comprises the inhalation of a naturally occurring terpene with chemotherapeutic properties known as perillyl alcohol (POH). Clinical trial results on recurrent GBM patients showed that POH extends the average life by more than eight months, temporarily slows tumor growth, and in some cases even decreases tumor size. After approximately seven months, the tumor continues to grow and l  ...[more]

Similar Datasets

| S-EPMC2834810 | biostudies-literature
| S-EPMC2907645 | biostudies-literature
| S-EPMC7879254 | biostudies-literature
| S-EPMC8305965 | biostudies-literature
| S-EPMC7137265 | biostudies-literature
| S-EPMC4577002 | biostudies-literature
2016-09-15 | GSE76383 | GEO
| S-EPMC5769394 | biostudies-literature
| S-EPMC9706323 | biostudies-literature
| S-ECPF-GEOD-7806 | biostudies-other